Chen J - Search Results

1

Synthesis, pharmacokinetics, and pharmacodynamics studies of valsartan peptide derivatives.

Wu C, Hu Y, Li Q, He L, Chen J, Cheng Z, Li Y, Hu G. Wu C, et al. Among authors: chen j. Arch Pharm (Weinheim). 2012 May;345(5):393-400. doi: 10.1002/ardp.201100377. Epub 2012 Jan 20. Arch Pharm (Weinheim). 2012. PMID: 22266917

2

Synthesis, pharmacophores, and mechanism study of pyridin-2(1H)-one derivatives as regulators of translation initiation factor 3A.

Zhu W, Shen J, Li Q, Pei Q, Chen J, Chen Z, Liu Z, Hu G. Zhu W, et al. Among authors: chen j, chen z. Arch Pharm (Weinheim). 2013 Sep;346(9):654-66. doi: 10.1002/ardp.201300138. Epub 2013 Aug 19. Arch Pharm (Weinheim). 2013. PMID: 23959654

3

Synthesis, resolution, and antiplatelet activity of 3-substituted 1(3H)-isobenzofuranone.

Yang H, Hu GY, Chen J, Wang Y, Wang ZH. Yang H, et al. Among authors: chen j. Bioorg Med Chem Lett. 2007 Sep 15;17(18):5210-3. doi: 10.1016/j.bmcl.2007.06.082. Epub 2007 Jul 1. Bioorg Med Chem Lett. 2007. PMID: 17632002

4

Synthesis and vasodilator effects of rutaecarpine analogues which might be involved transient receptor potential vanilloid subfamily, member 1 (TRPV1).

Chen Z, Hu G, Li D, Chen J, Li Y, Zhou H, Xie Y. Chen Z, et al. Among authors: chen j. Bioorg Med Chem. 2009 Mar 15;17(6):2351-9. doi: 10.1016/j.bmc.2009.02.015. Epub 2009 Feb 14. Bioorg Med Chem. 2009. PMID: 19254847

5

Design, synthesis and anti-fibrosis activity study of N₁-substituted phenylhydroquinolinone derivatives.

Wu L, Liu B, Li Q, Chen J, Tao L, Hu G. Wu L, et al. Among authors: chen j. Molecules. 2012 Feb 2;17(2):1373-87. doi: 10.3390/molecules17021373. Molecules. 2012. PMID: 22301723 Free PMC article.

6

Discovery of 1-(4-((3-(4-methylpiperazin-1-yl)propyl)amino)benzyl)-5-(trifluoromethyl)pyridin-2(1H)-one, an orally active multi-target agent for the treatment of diabetic nephropathy.

Chen J, Peng Z, Lu M, Xiong X, Chen Z, Li Q, Cheng Z, Jiang D, Tao L, Hu G. Chen J, et al. Among authors: chen z. Bioorg Med Chem Lett. 2018 Jan 15;28(2):222-229. doi: 10.1016/j.bmcl.2017.07.001. Epub 2017 Jul 4. Bioorg Med Chem Lett. 2018. PMID: 29248299

7

Cost-effectiveness Analysis of Pembrolizumab Plus Axitinib Versus Sunitinib in First-line Advanced Renal Cell Carcinoma in China.

Chen J, Hu G, Chen Z, Wan X, Tan C, Zeng X, Cheng Z. Chen J, et al. Among authors: chen z. Clin Drug Investig. 2019 Oct;39(10):931-938. doi: 10.1007/s40261-019-00820-6. Clin Drug Investig. 2019. PMID: 31250401

8

A novel asymmetric di-Ni(II) system as a highly efficient functional model for phosphodiesterase: synthesis, structures, physicochemical properties and catalytic kinetics.

Ren YW, Lu JX, Cai BW, Shi DB, Jiang HF, Chen J, Zheng D, Liu B. Ren YW, et al. Among authors: chen j. Dalton Trans. 2011 Feb 14;40(6):1372-81. doi: 10.1039/c0dt01194k. Epub 2010 Dec 22. Dalton Trans. 2011. PMID: 21180701

9

Phase I Trial of Pyragrel, a Novel Thromboxane Synthetase Inhibitor, to Evaluate the Safety, Tolerability, and Pharmacokinetics in Healthy Volunteers.

Zou C, Zuo X, Huang J, Hua Y, Yang S, Yang X, Guo C, Tan H, Chen J, Chu Z, Pei Q, Yang G. Zou C, et al. Among authors: chen j. Front Pharmacol. 2019 Oct 24;10:1231. doi: 10.3389/fphar.2019.01231. eCollection 2019. Front Pharmacol. 2019. PMID: 31708774 Free PMC article.

10

Simultaneous determination of Pyragrel, a novel anti-thrombotic agent, and its two primary metabolites in plasma by HPLC-MS/MS.

Yang G, Pei Q, Fu C, Huang J, Chen J, Yang S, Xiang Y, Wang J, Tan H, Liu X. Yang G, et al. Among authors: chen j. J Pharm Biomed Anal. 2018 Jul 15;156:199-205. doi: 10.1016/j.jpba.2018.04.010. Epub 2018 Apr 14. J Pharm Biomed Anal. 2018. PMID: 29727781

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

137,958 results

Search Page

Filters